139
Participants
Start Date
January 17, 2022
Primary Completion Date
November 26, 2024
Study Completion Date
November 26, 2024
Pertuzumab and tratuzumab fixed dose combination
Treatment administration: adjuvant pertuzumab and trastuzumab fixed dose combination SC for 14 cycles
Trastuzumab emtansine
Treatment administration: adjuvant T-DM1 for 14 cycles.
Icon Cancer Centre Wesley, Auchenflower
Ballarat Health Services, Ballarat
Bendigo Hospital, Bendigo
Sunshine Coast University Hospital, Birtinya
Box Hill Hospital, Box Hill
Chris O'Brien Lifehouse, Camperdown
Monash Medical Centre (Clayton), Clayton
Coffs Harbour Health Campus, Coffs Harbour
Concord Repatriation General Hospital, Concord
Townsville University Hospital, Douglas
Lake Macquarie Private Hospital, Gateshead
Gosford Hospital, Gosford
Royal Brisbane and Women's Hospital, Herston
Icon Cancer Centre Hobart, Hobart
Liverpool Hospital, Liverpool
Peter MacCallum Cancer Centre, Melbourne
Sir Charles Gairdner Hospital, Nedlands
Macquarie University, North Ryde
Mater Hospital, North Sydney
Sunshine Hospital, Saint Albans
Calvary Mater Newcastle, Waratah
Westmead Hospital, Westmead
Princess Alexandra Hospital, Woolloongabba
GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk, Antwerp
OLV ziekenhuis, Aalst
Cliniques Universtaires Saint-Luc, Brussels
Institut Jules Bordet, Brussels
Grand Hôpital de Charleroi, Charleroi
Heilig Hartziekenhuis, Lier
Centre Hospitalier Chretien MontLegia, Liège
CHU UCL Namur Sainte-Elisabeth, Namur
Institut de Cancérologie de l'Ouest - Angers, Angers
Institut Sainte Catherine, Avignon
Centre Hospitalier de la Côte Basque, Bayonne
CHRU Jean Minjoz, Besançon
Institut Bergonié, Bordeaux
Polyclinique Bordeaux Nord Aquitaine, Bordeaux
CHU Morvan, Brest
Centre François Baclesse, Caen
Centre Jean Perrin, Clermont-Ferrand
Centre Georges François Leclerc, Dijon
Hopital Michallon, Grenoble
Centre Oscar Lambret, Lille
CHU de Limoges, Limoges
GHBS Lorient, Lorient
Centre Léon Bérard, Lyon
Institut Paoli Calmettes, Marseille
CH Annecy Genevois, Metz-Tessy
Centre de Cancerologie du Grand Montpellier, Montpellier
Hopital privé du Confluent, Nantes
Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris
Hopital Tenon, Paris
Institut Curie - Paris, Paris
CH Perpignan, Perpignan
Hopital Lyon Sud, Pierre-Bénite
CHU Poitiers, Poitiers
Institut Godinot, Reims
Centre Henri Becquerel, Rouen
Institut Curie - Saint-Cloud, Saint-Cloud
Clinique Saint Anne, Strasbourg
Institut Claudius Regaud, Toulouse
Institut Gustave Roussy, Villejuif
Sheba Medical Center, Ramat Gan
Soon Chun Hyang University Cheonan Hospital, Cheonan
Keimyung University Dongsan Hospital, Daegu
National Cancer Center, Goyang-si
Gachon University Gil Medical Center, Incheon
Inha University Hospital, Incheon
Seoul National University Bundang Hospital, Seongnam
CHA bundang Medical Center, Seongnam-si
Asan Medical Center, Seoul
Ewha Womans University Mokdong Hospital, Seoul
Korea university anam hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Seoul ST. Mary's Hospital, Seoul
Severance Hospital, Seoul
Ajou University Hospital, Suwon
Ulsan University Hospital, Ulsan
Hirslanden Klinik - Tumor Zentrum, Aarau
Kantonsspital Baden, Baden
Universitatsspital Basel, Basel
Kantonsspital Frauenfeld/Frauenklinik, Frauenfeld
Hopital Daler - Centre du Sein, Fribourg
Kantonsspital Winterthur, Winterthur
Lead Sponsor
Collaborators (2)
Breast International Group
OTHER
Hoffmann-La Roche
INDUSTRY
International Drug Development Institute
OTHER
Institut Curie
OTHER
Jules Bordet Institute
OTHER